Company Filing History:
1 out of 497 
1 out of 258 Years Active: 2022
Title: Innovations of Xiaoyu Zhang in Cancer Research
Introduction
Xiaoyu Zhang is a prominent inventor based in Toronto, Canada. She has made significant contributions to the field of cancer research through her innovative work on CD133-binding agents. Her research focuses on the detection and quantification of CD133-expressing cells, which play a crucial role in cancer progression.
Latest Patents
Xiaoyu Zhang holds a patent for her invention titled "CD133-binding agents and uses thereof." This patent is directed towards novel CD133-binding agents that can be utilized for various applications, including detecting CD133-expressing cells, targeting these cells, and decreasing levels of CD133 in such cells. The implications of her work are significant for the treatment and prevention of cancer.
Career Highlights
Throughout her career, Xiaoyu Zhang has worked with esteemed institutions such as the University of Toronto and McMaster University. Her research has garnered attention for its potential to advance cancer therapies and improve patient outcomes.
Collaborations
Xiaoyu has collaborated with notable colleagues, including Jason Moffat and Jarrett Adams, to further her research initiatives. Their combined expertise has contributed to the development of innovative solutions in the field of cancer research.
Conclusion
Xiaoyu Zhang's work exemplifies the impact of innovative research on cancer treatment. Her contributions through her patent and collaborations highlight the importance of continued exploration in this critical area of health.